Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#71 / 99 Total
EVRI - Everi Holdings Inc - Stock Price Chart
TickerEVRI [NYSE, RUT]
CompanyEveri Holdings Inc
CountryUSA
IndustryGambling
Market Cap702.58MEPS (ttm)0.90
P/E9.28EPS this Y-1.21%
Forward P/E8.30EPS next Y12.33%
PEG0.46EPS past 5Y40.40%
P/S0.86EPS next 5Y20.00%
P/B3.10EPS Q/Q-92.47%
Dividend7.76%Sales Q/Q-6.36%
Insider Own3.10%Inst Own94.02%
Insider Trans0.00%Inst Trans-1.68%
Short Float5.30%EarningsMay 08/b
Analyst Recom2.00Target Price12.67
Avg Volume1.12M52W Range8.30 - 17.85
Everi Holdings, Inc. engages in the provision of technology solutions to the casino, interactive, and gaming industry. It operates through the Games and Financial Technology Solutions (FinTech) segments. The Games segment focuses on leased gaming equipment, sales of gaming equipment, gaming systems, interactive solutions, and ancillary products and services. The FinTech segment provides access to cash at gaming facilities via ATM cash withdrawals, credit card cash access transactions and point of sale debit card cash access transactions, check-related services, fully integrated kiosks and maintenance services, compliance, audit and data software, casino credit data, and reporting services and other ancillary offerings. The company was founded on February 4, 2004 and is headquartered in Las Vegas, NV.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lowenhar-Fisher Kate C.EVP, Chief Legal OfficerMar 22 '24Option Exercise0.0016,666050,011Mar 22 06:27 PM
JUDGE GEOFFREY PDirectorNov 30 '23Option Exercise7.747,00054,18091,572Dec 01 04:03 PM
TAYLOR RANDY LPresident & CEOAug 29 '23Option Exercise6.5960,000395,400582,622Aug 30 06:17 PM
Rumbolz Michael DExecutive ChairmanAug 29 '23Option Exercise6.5950,000329,5001,108,320Aug 30 06:14 PM
TAYLOR RANDY LPresident & CEOAug 29 '23Buy14.275,00071,350522,622Aug 30 06:17 PM
SIBN - SI-BONE Inc - Stock Price Chart
TickerSIBN [NASD, RUT]
CompanySI-BONE Inc
CountryUSA
IndustryMedical Devices
Market Cap598.24MEPS (ttm)-1.13
P/E-EPS this Y12.54%
Forward P/E-EPS next Y22.60%
PEG-EPS past 5Y12.47%
P/S4.31EPS next 5Y8.90%
P/B3.50EPS Q/Q16.22%
Dividend-Sales Q/Q21.61%
Insider Own9.89%Inst Own88.98%
Insider Trans-2.46%Inst Trans-0.55%
Short Float7.01%EarningsMay 06/a
Analyst Recom1.00Target Price26.22
Avg Volume425.49K52W Range14.26 - 29.51
SI-BONE, Inc. is a medical device company, which engages in the provision of a proprietary minimally invasive surgical implant system to fuse the sacroiliac joint for treatment of musculoskeletal disorders of the sacropelvic anatomy. It offers a proprietary minimally invasive surgical implant system, called iFuse, used to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that often causes severe lower back pain. The company was founded by Mark A. Reiley and Jeffrey W. Dunn on March 18, 2008 and is headquartered in Santa Clara, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
RECUPERO ANTHONY JPresident, Commercial OpsApr 03 '24Sale15.6392014,379251,533Apr 04 07:59 PM
RECUPERO ANTHONY JPresident, Commercial OpsApr 02 '24Sale15.503,30751,272252,453Apr 04 07:59 PM
Maheshwari AnshulChief Financial OfficerApr 02 '24Sale15.452,42537,474205,516Apr 04 07:59 PM
RECUPERO ANTHONY JPresident, Commercial OpsMar 13 '24Sale16.823,33056,023255,760Mar 14 05:46 PM
Nishimura MikaDirectorMar 13 '24Sale16.222,50040,55019,350Mar 14 05:45 PM
SLRN - Acelyrin Inc - Stock Price Chart
TickerSLRN [NASD, RUT]
CompanyAcelyrin Inc
CountryUSA
IndustryBiotechnology
Market Cap419.38MEPS (ttm)-3.92
P/E-EPS this Y24.27%
Forward P/E-EPS next Y-15.86%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B0.63EPS Q/Q-526.06%
Dividend-Sales Q/Q-
Insider Own37.98%Inst Own72.81%
Insider Trans-0.10%Inst Trans-
Short Float12.79%EarningsMar 28/a
Analyst Recom1.40Target Price31.00
Avg Volume1.23M52W Range4.22 - 29.88
ACELYRIN, Inc. operates as a biopharma company. It engages in identifying, acquiring, and accelerating the development and commercialization of transformative medicines. The company was founded by Shao-Lee Lin on July 27, 2020 and is headquartered in Agoura Hills, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lin Shao-LeeChief Executive OfficerApr 01 '24Sale6.639,96166,0241,577,374Apr 03 06:18 PM
Lin Shao-LeeChief Executive OfficerFeb 20 '24Sale7.6015,701119,4031,587,335Feb 22 07:04 PM
Lin Shao-LeeChief Executive OfficerJan 02 '24Sale7.4110,69179,1881,603,036Jan 04 06:09 PM
Westlake BioPartners Fund II, 10% OwnerMay 09 '23Buy18.001,250,00022,500,0009,790,729May 11 09:16 PM
SEIDENBERG BETH CDirectorMay 09 '23Buy18.001,250,00022,500,0009,790,729May 11 09:13 PM
TTEC - TTEC Holdings Inc - Stock Price Chart
TickerTTEC [NASD, RUT]
CompanyTTEC Holdings Inc
CountryUSA
IndustryInformation Technology Services
Market Cap366.16MEPS (ttm)0.18
P/E43.40EPS this Y-32.44%
Forward P/E4.09EPS next Y28.10%
PEG-EPS past 5Y-25.46%
P/S0.15EPS next 5Y-
P/B0.61EPS Q/Q-144.18%
Dividend7.41%Sales Q/Q-5.25%
Insider Own59.63%Inst Own37.42%
Insider Trans0.00%Inst Trans-1.96%
Short Float16.76%EarningsMay 08/a
Analyst Recom2.43Target Price15.30
Avg Volume368.73K52W Range7.73 - 36.70
TTEC Holdings, Inc. is a digital global customer experience technology and services company. It focuses on the design, implementation, and delivery of transformative solutions for many brands. The firm operates through the following segments: TTEC Digital and TTEC Engage. The TTEC Digital segment provides design, build, and operate tech-enabled, insight-driven CX solutions. The TTEC Engage segment provides digitally-enabled customer care, acquisition, and fraud prevention services. The company was founded by Kenneth D. Tuchman in 1982 and is headquartered in Greenwood Village, CO.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bourret FrancoisCHIEF ACCOUNTING OFFICERApr 14 '24Option Exercise0.001,19106,004Apr 16 04:44 PM
McLean Margaret BGC & CROApr 14 '24Option Exercise0.001,634054,757Apr 16 04:51 PM
Bourret FrancoisCHIEF ACCOUNTING OFFICERMar 17 '24Option Exercise0.002,71805,832Mar 19 04:35 PM
Swanback Michelle RPRESIDENT, CEO, TTEC ENGAGEMar 16 '24Option Exercise0.0010,986019,672Mar 19 04:31 PM
McLean Margaret BGC & CROMar 04 '24Option Exercise0.00612052,306Mar 06 04:39 PM
HBIO - Harvard Bioscience Inc. - Stock Price Chart
TickerHBIO [NASD, RUT]
CompanyHarvard Bioscience Inc.
CountryUSA
IndustryMedical Instruments & Supplies
Market Cap157.11MEPS (ttm)-0.08
P/E-EPS this Y50.00%
Forward P/E12.48EPS next Y38.10%
PEG-EPS past 5Y6.80%
P/S1.40EPS next 5Y10.00%
P/B2.15EPS Q/Q-7.58%
Dividend-Sales Q/Q-0.96%
Insider Own7.16%Inst Own76.69%
Insider Trans0.00%Inst Trans-2.27%
Short Float1.67%EarningsMar 07/b
Analyst Recom1.00Target Price6.92
Avg Volume87.63K52W Range3.47 - 6.29
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. It operates under the geographical segments: United States, Germany, United Kingdom, and Rest of the world. It sells its products through catalog, Website, distributors, and direct sales force. The company was founded by Dr. William T. Porter in 1901 and is headquartered in Holliston, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Green James WChief Executive OfficerAug 17 '23Buy4.3825,000109,5002,862,679Aug 21 04:06 PM
GILD - Gilead Sciences, Inc. - Stock Price Chart
TickerGILD [NASD, NDX, S&P 500]
CompanyGilead Sciences, Inc.
CountryUSA
IndustryDrug Manufacturers - General
Market Cap81.58BEPS (ttm)0.36
P/E182.38EPS this Y-43.71%
Forward P/E9.08EPS next Y90.42%
PEG33.92EPS past 5Y1.55%
P/S2.98EPS next 5Y5.38%
P/B4.67EPS Q/Q-517.48%
Dividend4.79%Sales Q/Q5.66%
Insider Own0.10%Inst Own85.74%
Insider Trans-2.00%Inst Trans0.85%
Short Float1.70%EarningsApr 25/a
Analyst Recom2.22Target Price83.95
Avg Volume7.32M52W Range65.09 - 87.86
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GILEAD SCIENCES, INC.10% OwnerApr 02 '24Buy0.76485,250368,7907,345,473Apr 03 06:50 PM
Parsey MerdadChief Medical OfficerApr 01 '24Sale72.962,000145,92096,304Apr 02 06:38 PM
Parsey MerdadChief Medical OfficerFeb 29 '24Sale72.748,230598,62492,706Feb 29 06:35 PM
Parsey MerdadChief Medical OfficerFeb 28 '24Sale73.182,000146,360100,936Feb 29 06:35 PM
GILEAD SCIENCES, INC.10% OwnerFeb 12 '24Buy22.00910,00020,020,0004,126,119Feb 13 05:48 PM
WHR - Whirlpool Corp. - Stock Price Chart
TickerWHR [NYSE]
CompanyWhirlpool Corp.
CountryUSA
IndustryFurnishings, Fixtures & Appliances
Market Cap5.15BEPS (ttm)7.22
P/E13.11EPS this Y-19.81%
Forward P/E6.70EPS next Y9.03%
PEG-EPS past 5Y-
P/S0.27EPS next 5Y-11.67%
P/B2.21EPS Q/Q-44.43%
Dividend7.44%Sales Q/Q-3.44%
Insider Own2.82%Inst Own91.97%
Insider Trans0.00%Inst Trans-2.98%
Short Float13.39%EarningsApr 24/a
Analyst Recom2.89Target Price105.98
Avg Volume1.49M52W Range92.54 - 160.62
Whirlpool Corp. engages in the manufacturing and marketing of home appliances. Its products include home laundry appliances, refrigerators and freezers, cooking appliances, home dishwashers, and room air-conditioning equipment, mixers, and portable household appliances. The firm's brands include Whirlpool, KitchenAid, Maytag, Consul, Brastemp, Amana, Bauknecht, JennAir, and Indesit. It operates through the following segments: North America, Europe, Middle East and Africa (EMEA), Latin America, and Asia. The company was founded by Emory Upton, Fred Upton, and Louis C. Upton on November 11, 1911 and is headquartered in Fall River, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Perucchetti AlessandroEVP, Whirlpool North AmericaMar 01 '24Option Exercise0.0065806,425Mar 05 06:23 PM
Conley Christopher SVice President and ControllerMar 01 '24Option Exercise0.0096803,591Mar 05 06:18 PM
Puente Juan CarlosEVP & PRES. WHIRLPOOL LARMar 01 '24Option Exercise0.001,004019,336Mar 05 06:20 PM
Peters James WEXEC VICE PRESIDENT AND CFOMar 01 '24Option Exercise0.009,606050,370Mar 05 06:21 PM
Harter AvaEVP & Chief Legal OfficerMar 01 '24Option Exercise0.004,288011,581Mar 05 06:30 PM
VOXX - VOXX International Corp - Stock Price Chart
TickerVOXX [NASD, RUT]
CompanyVOXX International Corp
CountryUSA
IndustryConsumer Electronics
Market Cap145.09MEPS (ttm)-1.64
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-104.06%
P/S0.29EPS next 5Y10.00%
P/B0.46EPS Q/Q-72.96%
Dividend-Sales Q/Q-5.45%
Insider Own57.88%Inst Own49.44%
Insider Trans0.00%Inst Trans-7.92%
Short Float2.84%EarningsJan 09/a
Analyst Recom1.00Target Price11.00
Avg Volume29.30K52W Range6.34 - 13.35
VOXX International Corp. engages in the manufacture and distribution of consumer electronic products. It operates through the following segments: Automotive Electronics, Consumer Electronics, and Biometrics. The Automotive Electronics segment offers products including entertainment devices, automotive security, remote start systems, mobile multimedia devices, and car-link smartphone telematics applications. The Consumer Electronics segment designs, manufactures, distributes, and markets products including home theater systems, high-end loudspeakers, outdoor speakers, business music systems, and cinema speakers. The Biometrics segment provides iris identification and biometric security related products. The company was founded by John J. Shalam in 1960 and is headquartered in Orlando, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Downing Steven RDirectorJan 05 '24Buy10.001,568,75015,687,5003,312,558Jan 08 12:06 PM
Kahli BeatPresidentJan 05 '24Sale10.001,568,75015,687,500397,500Jan 09 09:27 AM
Downing Steven RDirectorOct 06 '23Buy10.001,570,00015,700,0001,743,808Oct 10 04:09 PM
Kahli BeatPresidentOct 06 '23Sale10.001,568,75015,687,500598,750Oct 10 04:05 PM
Downing Steven RDirectorAug 21 '23Buy8.655,00043,250173,808Aug 22 02:52 PM
RVNC - Revance Therapeutics Inc - Stock Price Chart
TickerRVNC [NASD, RUT]
CompanyRevance Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap354.35MEPS (ttm)-3.79
P/E-EPS this Y20.20%
Forward P/E-EPS next Y57.85%
PEG-EPS past 5Y0.57%
P/S1.51EPS next 5Y11.60%
P/B-EPS Q/Q66.08%
Dividend-Sales Q/Q39.82%
Insider Own8.63%Inst Own75.24%
Insider Trans0.01%Inst Trans13.79%
Short Float12.21%EarningsFeb 28/a
Analyst Recom1.75Target Price14.91
Avg Volume1.81M52W Range3.23 - 37.98
Revance Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development, manufacturing, and commercialization of novel botulinum toxin products for multiple aesthetic and therapeutic applications. The firm focuses on production of daxibotulinumtoxinA, a botulinum toxin, for aesthetic and therapeutic indications including facial wrinkles and muscle movement disorders. The company was founded by Jacob M. Waugh and L. Daniel Browne on August 10, 1999 and is headquartered in Nashville, TN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Jordan EricaChief Commercial OfficerApr 16 '24Sale3.802,3929,096114,864Apr 17 04:34 PM
Schilke TobinCFOMar 18 '24Sale5.049,36147,204192,666Mar 19 06:44 PM
Sjuts Dustin SPresidentMar 18 '24Sale5.049,21146,446167,550Mar 19 06:45 PM
Moxie DwightCLO & GCMar 18 '24Sale5.048,12540,971137,815Mar 19 06:44 PM
Foley Mark JCEOMar 06 '24Buy6.9830,000209,4001,015,468Mar 08 04:33 PM
WNS - WNS (Holdings) Limited - Stock Price Chart
TickerWNS [NYSE]
CompanyWNS (Holdings) Limited
CountryIndia
IndustryInformation Technology Services
Market Cap1.83BEPS (ttm)2.83
P/E14.19EPS this Y1.37%
Forward P/E8.06EPS next Y12.24%
PEG1.33EPS past 5Y7.18%
P/S1.39EPS next 5Y10.71%
P/B2.40EPS Q/Q-65.46%
Dividend-Sales Q/Q6.93%
Insider Own11.62%Inst Own93.87%
Insider Trans0.00%Inst Trans2.19%
Short Float1.53%EarningsApr 25/b
Analyst Recom1.33Target Price57.70
Avg Volume440.53K52W Range40.06 - 91.88
Apr-26-24Downgrade Deutsche Bank Buy → Hold $64 → $44
WNS (Holdings) Ltd. engages in the provision of business process management solutions. Its services include industry-specific offerings, customer interaction, finance and accounting, human resources, procurement, and research and analytics. It operates through the WNS Global BPM and WNS Auto Claims BPM segments. The WNS Global BPM is delivered out of its delivery centers in China Costa Rica, India, the Philippines, Poland, Romania, South Africa, Sri Lanka, the United Kingdom, and the U.S. The WNS Auto Claims BPM segment offers fault and non-fault repairs and legal services in relation to personal injury claims. The company was founded by Alan Stephen Dunning, David Charles Tibble and Neeraj Bhargava on February 18, 2002 and is headquartered in Mumbai, India.
12345678910